Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,059 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05156736Recruiting
Study of early heart artery disease in South Asians
This study looks at early buildup of plaque in heart arteries in young adults from Pakistan. It may help doctors understand why this happens earlier and guide better prevention and screening.
Karachi, SindhAges 35–65 - NCT06273761Recruiting
Medication management service for diabetes and high blood pressure
This study tests a medication management service for people with type 2 diabetes and/or high blood pressure who take many medications. It aims to help you better manage your medicines and avoid urgent medical visits.
Hong KongAges 18 years+ - NCT06305208Recruiting
UK registry for weight loss endoscopy procedures
This study collects information from patients in the UK who have a weight loss procedure done through an endoscope (a thin tube down the throat). It helps doctors learn more about how well these procedures work and how safe they are.
LondonAges 18–99 - NCT06310148Recruiting
Preventing chronic disease in Hong Kong adults aged 45+
This study looks at a new program in Hong Kong that helps people without diabetes or hypertension learn how to prevent or manage chronic diseases. One group gets extra support through a local health centre, and the other group follows usual care.
Hong KongAges 45 years+ - NCT03323216Recruiting
Testing heart-related blood markers in people with diabetes and heart failure
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT07783802RecruitingPhase 2
Study of clazakizumab for adults with high inflammation and heart risk
This study tests whether clazakizumab can reduce the risk of heart attacks or strokes in people with high levels of inflammation (measured by a blood test called hsCRP) and conditions like heart disease, obesity, diabetes, high blood pressure, or kidney disease. If you qualify, you'll receive either the study drug or a placebo to see if it helps lower your risk.
Huntsville, AlabamaAges 18 years+ - NCT07684144RecruitingPhase 3
Long-term study of a weight-loss medication for people who completed an earlier trial
This study tests the long-term effects of a medication called maridebart cafraglutide for weight management. It is for people who already completed a 72-week study of this drug and want to continue treatment.
Gilbert, ArizonaAges 18–99 - NCT07673822Enrolling by invitation
Heart, kidney, and metabolic disease study in Korea
This study looks at how common heart, kidney, and metabolic problems are in Korea by using health insurance records. It will help doctors understand how often these conditions happen together.
SeoulAges 19 years+ - NCT07678671Enrolling by invitation
Blood sugar control with a health education program
This study tests whether a simple educational program called Ask Me 3 helps people with type 2 diabetes better control their blood sugar. It may be a good fit if you get your diabetes care at Hospital Clínica Nova and want to learn more about managing your condition.
San Nicolás de los Garza, Nuevo LeónAges 18–80 - NCT06591286Recruiting
Real-time CGM for blood sugar after hospital discharge
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05165706Recruiting
Study of how obesity affects insulin resistance over time
This study follows adults over time to understand how weight and body chemistry relate to insulin resistance. It may help researchers learn why insulin resistance happens and what could prevent or improve it.
Stanford, CaliforniaAges 35–65 - NCT07595718Recruiting
Using health data and AI to predict major diseases
This study uses your health information and artificial intelligence to help predict the onset of major diseases. By joining, you could help improve early detection and prevention for conditions like diabetes, heart disease, and cancer.
Seoul, Seoul Special CityAges 30–65 - NCT07588438RecruitingPhase 4
Tirzepatide effectiveness and safety for diabetes and weight loss in Paraguay
This study tests how well and safely tirzepatide (a new injectable medication) works in real-world conditions for people with type 2 diabetes or obesity in Paraguay. The medication helps lower blood sugar and reduce weight.
AsunciónAges 18–70 - NCT07570992RecruitingPhase 1
Safety study of NNC1679-0001 in healthy people and people with type 2 diabetes
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
GrazAges 18–64 - NCT06638567Recruiting
Comparing insulin methods after surgery for type 2 diabetes
This trial tests two ways to give insulin after gastrointestinal or vascular surgery to see which one leads to fewer wound infections. It may help if you have type 2 diabetes and are having one of these surgeries.
AmsterdamAges 18 years+ - NCT07401992RecruitingPhase 4
Semaglutide for psoriasis and weight management
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
Monterrey, N.L.Ages 18 years+ - NCT06323538Recruiting
Plant-based diets and health (COPLANT)
This study looks at how different plant-based diets affect your health. Researchers will collect information through questionnaires and blood samples to understand the benefits of eating more plants.
ViennaAges 18–69 - NCT07360938Recruiting
How inflammation affects drug processing
This study looks at how inflammation from conditions like diabetes, IBD, or kidney disease affects the way drugs work in the body. It may help improve dosing and safety for patients with these conditions.
Indianapolis, IndianaAges 12–99 - NCT07317102Recruiting
Omnipod 5 study in France: real-world results
This study is testing how well the Omnipod 5 insulin pump works in everyday life for people with type 1 diabetes. It's for people who are just starting to use this pump, so doctors can see how it helps manage blood sugar in real-world settings.
AngersAges 2 years+ - NCT06366399Recruiting
Timing of resistance exercise for weight management
This study tests if doing resistance exercises (like lifting weights) in the morning or afternoon is better for weight management. You may qualify if you are between 50 and 74 years old, are overweight but generally healthy, and have not been very active with strength training.
Salt Lake City, UtahAges 50–74 - NCT05404061Recruiting
Study for people who don’t lose weight after bariatric surgery
This study looks at people who have had bariatric surgery but still struggle to lose weight (or lose it poorly). It aims to better understand how to help “poor responders” and what might be interfering with weight-loss results.
LondonAges 18–70 - NCT07065383Recruiting
Testing a drug and exercise for heart and muscle fat in diabetes
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Aberdeen, AberdeenshireAges 20–75 - NCT06989164Recruiting
How Your Body Responds to Different Foods After Eating
This study looks at how different foods affect your body after eating, especially your blood sugar and other metabolic responses. It may help find personalized ways to eat better for your health.
Stanford, CaliforniaAges 18–80 - NCT06862739RecruitingPhase 4
Testing a 3-drug combination for better blood sugar control
This study tests a combination of three diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps control blood sugar in people with type 2 diabetes. It may be an option if your current treatment isn't working well enough.
Faisalabad, Punjab ProvinceAges 18–80
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,059 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.